TY - JOUR
T1 - Codon usage regulates human KRAS expression at both transcriptional and translational levels
AU - Fu, Jingjing
AU - Dang, Yunkun
AU - Counter, Christopher
AU - Liu, Yi
N1 - Funding Information:
This work was supported by National Institutes of Health Grant 1R35GM118118, Cancer Prevention and Research Institute of Texas Grant RP160268, Welch Foundation Grant I-1560 (to Y. L.), and National Institutes of Health Grants R01CA94184 and P01CA203657 (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2018 Fu et al.
PY - 2018/11/16
Y1 - 2018/11/16
N2 - KRAS and HRAS are highly homologous oncogenic Ras GTPase family members that are mutated in a wide spectrum of human cancers. Despite having high amino acid identity, KRAS and HRAS have very different codon usage biases: the HRAS gene contains many common codons, and KRAS is enriched for rare codons. Rare codons in KRAS suppress its protein expression, which has been shown to affect both normal and cancer biology in mammals. Here, using HRAS or KRAS expression in different human cell lines and in vitro transcription and translation assays, we show that KRAS rare codons inhibit both translation efficiency and transcription and that the contribution of these two processes varies among different cell lines. We observed that codon usage regulates mRNA translation efficiency such that WT KRAS mRNA is poorly translated. On the other hand, common codons increased transcriptional rates by promoting activating histone modifications and recruitment of transcriptional coactivators. Finally, we found that codon usage also influences KRAS protein conformation, likely because of its effect on co-translational protein folding. Together, our results reveal that codon usage has multidimensional effects on protein expression, ranging from effects on transcription to protein folding in human cells.
AB - KRAS and HRAS are highly homologous oncogenic Ras GTPase family members that are mutated in a wide spectrum of human cancers. Despite having high amino acid identity, KRAS and HRAS have very different codon usage biases: the HRAS gene contains many common codons, and KRAS is enriched for rare codons. Rare codons in KRAS suppress its protein expression, which has been shown to affect both normal and cancer biology in mammals. Here, using HRAS or KRAS expression in different human cell lines and in vitro transcription and translation assays, we show that KRAS rare codons inhibit both translation efficiency and transcription and that the contribution of these two processes varies among different cell lines. We observed that codon usage regulates mRNA translation efficiency such that WT KRAS mRNA is poorly translated. On the other hand, common codons increased transcriptional rates by promoting activating histone modifications and recruitment of transcriptional coactivators. Finally, we found that codon usage also influences KRAS protein conformation, likely because of its effect on co-translational protein folding. Together, our results reveal that codon usage has multidimensional effects on protein expression, ranging from effects on transcription to protein folding in human cells.
UR - http://www.scopus.com/inward/record.url?scp=85056598205&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056598205&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA118.004908
DO - 10.1074/jbc.RA118.004908
M3 - Article
C2 - 30275015
AN - SCOPUS:85056598205
SN - 0021-9258
VL - 293
SP - 17929
EP - 17940
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 46
ER -